Please assess the completion status of the following clinical trial:

Trial Title: Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE2/PHASE3
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically confirmed squamous cell anal carcinoma~  * Keratinizing or non-keratinizing~ * The following stages are eligible:~    * T2, N0, M0 with maximum tumor diameter at least 4 cm~   * T3-T4, N0, M0~   * Any T, N1-N3, M0~* Tumor located in the anal canal OR in the anal margin and infiltrating the anal canal~* No primary adenocarcinoma of the anus~* Measurable disease~PATIENT CHARACTERISTICS:~Age~* 18 to 75~Performance status~* WHO 0-1~Life expectancy~* Not specified~Hematopoietic~* Granulocyte count greater than 2,000/mm\^3~* Platelet count greater than 100,000/mm\^3~Hepatic~* Not specified~Renal~* Creatinine less than 1.4 mg/dL~Cardiovascular~* No grade I angina pectoris with clinical symptoms within the past 3 months~* No grade II-IV angina pectoris within the past 3 months~* No stage II or greater distal arteritis~Other~* Not pregnant or nursing~* Fertile patients must use effective contraception~* No other prior malignancy except adequately treated basal cell skin cancer or carcinoma in situ of the cervix~* No psychological, familial, sociological, or geographical condition that would preclude study compliance and follow-up~PRIOR CONCURRENT THERAPY:~Biologic therapy~* Not specified~Chemotherapy~* No other concurrent chemotherapy~Endocrine therapy~* Not specified~Radiotherapy~* No other concurrent radiotherapy~Surgery~* No prior colostomy~Other~* No prior treatment for anal cancer

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).